Biolidics Limited

Equities

8YY

SGXE89830751

Advanced Medical Equipment & Technology

Market Closed - Singapore S.E. Other stock markets 05:04:34 2024-04-26 am EDT			5-day change	1st Jan Change
0.012 ^SGD	0.00%		0.00%	-14.29%

Apr. 12	Biolidics Limited Announces the Redesignation of Zhu Hua from Non-Executive Non-Independent Director to Executive Director	CI
Apr. 12	Singapore Shares Fall at Market Close; Biolidics Up 9%	MT

Biolidics Limited Appoints Zhu Hua as A Non-Executive Non-Independent Director

December 01, 2023 at 05:06 am EST

Biolidics Limited appointed Mr. Zhu Hua as a Non-Executive Non-Independent Director of the Company. Working Experience: 1. Zhenghe Antai (Beijing) Investment Management Co. Ltd. (Director and General Manager - November 2006 to current) 2. Microbeam Software Technology (Shanghai) Limited (Director - September 2014 to November 2018) 3. Khorgos Weiniao Technology Limited (Supervisor - December 2018 to current) 4. Edge Mediatech Pte.

Ltd. (Chief Financial Officer - February 2023 to current). Appointment Date is December 1, 2023.

Latest news about Biolidics Limited

Biolidics Limited Announces the Redesignation of Zhu Hua from Non-Executive Non-Independent Director to Executive Director	Apr. 12	CI
Singapore Shares Fall at Market Close; Biolidics Up 9%	Apr. 12	MT
Biolidics’ Loss Narrows in 2023 as Revenue Slumps 47%; Shares Surge 9%	Apr. 11	MT
Biolidics to Issue Shares Worth Over SG$360,000 to New Director	Mar. 20	MT
Biolidics Limited Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Biolidics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Biolidics Limited Announces the Change of its Registered Office Address	Jan. 26	CI
Biolidics Issues Over 87 Million Shares to Sponsor, Investor	Jan. 11	MT
Biolidics Obtains Bourse's Nod to List Over 87 Million Shares	Jan. 08	MT
Biolidics to Issue SG$50,000 of Shares to Sponsor as Partial Payment of Professional Fee	Dec. 28	MT
Biolidics to Raise Over SG$1 Million from Share Placement	Dec. 22	MT
Biolidics Ropes in Evolve Capital Advisory as Sponsor	Dec. 20	MT
Biolidics Limited Appoints Zhu Hua as A Non-Executive Non-Independent Director	Dec. 01	CI
Clearbridge Health Receives Full Amount of Outstanding Debt from Biolidics	Nov. 30	MT
Biolidics Issues 98.5 Million Shares Under Subscription Agreement; Shares Jump 8%	Nov. 28	MT
Biolidics Obtains Regulatory Nod to List 98.5 Million Shares Under Subscription Agreement	Nov. 27	MT
Biolidics Limited Announces Board Changes	Nov. 27	CI
Singapore Stocks End Week in Red; Noel Gifts Zooms 38% as Collective Sale of 50 Playfair Road Singapore Closes	Nov. 24	MT
Clearbridge Health Unit, Biolidics Sign Deal for Partial Debt Settlement	Nov. 24	MT
Biolidics to Raise Over SG$1 Million in Share Subscription Agreement	Nov. 22	MT
Biolidics Requests Trading Halt Pending News	Nov. 21	MT
Biolidics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Biolidics Signs Agreement to Raise SG$1.5 Million from Share Placement	23-10-12	MT
Singapore Stocks Loses Further Ground Tracking Global Losses; Datapulse Technology Slips 3% as Takeover Offer Closes	23-10-04	MT
Biolidics to Raise SG$1.5 Million from Share Placement; Shares Jump 8%	23-10-03	MT

Chart Biolidics Limited

Duration

Period

More charts

Company Profile

Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singaporeâs Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-28 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BIOLIDICS LIMITED	-14.29%	6.56M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology